SuperworthNeumora Therapeutics shares outstanding NMRA
Diluted shares outstanding, averaged over each quarter, from 2022.
- Latest quarter, to Jun 30, 2026
- 185.2M
- On a year earlier
- +14.5%
- more shares
Neumora Therapeutics had 185.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 14.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 168.5M | +5% |
| FY2024 | 161M | +5% |
| FY2023 | 152.8M | +440% |
| FY2022 | 28.3M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 185.2M | +15% | |
| Q1 FY26 | 179.9M | +11% | |
| Q4 FY25 | 168.5M | +5% | |
| Q3 FY25 | 161.8M | +1% | |
| Q2 FY25 | 161.7M | +2% | |
| Q1 FY25 | 161.5M | +2% | |
| Q4 FY24 | 161M | +5% | |
| Q3 FY24 | 159.6M | +242% | |
| Q2 FY24 | 159M | +428% | |
| Q1 FY24 | 157.9M | +439% | |
| Q4 FY23 | 152.8M | +440% | |
| Q3 FY23 | 46.7M | +69% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Neumora Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.